Andrew G. Bostom, MD, MS; Irwin H. Rosenberg, MD; Halit Silbershatz, PhD; Paul F. Jacques, ScD; Jacob Selhub, PhD; Ralph B. D'Agostino, PhD; Peter W.F. Wilson, MD; Philip A. Wolf, MD
Bostom AG, Rosenberg IH, Silbershatz H, Jacques PF, Selhub J, D'Agostino RB, et al. Nonfasting Plasma Total Homocysteine Levels and Stroke Incidence in Elderly Persons: The Framingham Study. Ann Intern Med. 1999;131:352-355. doi: 10.7326/0003-4819-131-5-199909070-00006
Download citation file:
Published: Ann Intern Med. 1999;131(5):352-355.
Total homocysteine levels are associated with arteriosclerotic outcomes.
To determine whether total homocysteine levels predict incident stroke in elderly persons.
Prospective population-based cohort study with 9.9 years of follow-up.
1947 Framingham Study participants (1158 women and 789 men; mean age Â± SD, 70 Â± 7 years).
Baseline total homocysteine levels and 9.9-year stroke incidence.
The quartiles of nonfasting total homocysteine levels were as follows: quartile 1, 4.13 to 9.25 Âµmol/L; quartile 2, 9.26 to 11.43 Âµmol/L; quartile 3, 11.44 to 14.23 Âµmol/L; quartile 4, 14.24 to 219.84 Âµmol/L. During follow-up, 165 incident strokes occurred. In proportional hazards models adjusted for age, sex, systolic blood pressure, diabetes, smoking, and history of atrial fibrillation and coronary heart disease, relative risk (RR) estimates comparing quartile 1 with the other three quartiles were as follows: quartile 2 compared with quartile 1â€”RR, 1.32 (95% CI, 0.81 to 2.14); quartile 3 compared with quartile 1â€”RR, 1.44 (CI, 0.89 to 2.34); quartile 4 compared with quartile 1â€”RR, 1.82 (CI, 1.14 to 2.91). The linear trend across the quartiles was significant (PÂ <Â 0.001).
Nonfasting total homocysteine levels are an independent risk factor for incident stroke in elderly persons.
Learn more about subscription options.
Register Now for a free account.
Geriatric Medicine, Neurology, Stroke.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only